Search Browse Earnings

BioRestorative Therapies, Inc.

Nasdaq:BRTX

Services-Misc Health & Allied Services, NEC·MELVILLE, NY

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

$145,800

+21.7% YoY

FY 2024

Adj. EBITDA

-$15.1M

-10378.4% margin

FY 2024

Net Income

-$10.4M

-7145.2% margin

FY 2024

EPS (Diluted)

-$2.47

FY 2024

Stock Price

$0.28

+19.9%

2026-03-10

52W Range

$0.19 – $2.10

P/E Ratio

-0.1x

Market Cap

$2.5M

Cash

$884,377

FY 2024

Total Debt

$255,846

FY 2011

Net Cash

$628,531

FY 2011

Enterprise Value

$1.9M

Debt / EBITDA

0.0x

FY 2024

EV / EBITDA

-0.1x

Employees

—